Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2000
08/23/2000EP1028727A1 Skin penetration enhancing components
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/23/2000CN1264365A 3-benzoylindole derivatives and drugs containing the same
08/23/2000CN1264304A Lipid-based immune modulator composition
08/23/2000CN1264294A Liquid antimicrobial cleansing compositions
08/23/2000CN1263777A Tibetan-medicinal bath for treating rheumatism and its preparing process
08/23/2000CN1263771A Black plaster and preparing process thereof
08/23/2000CN1263764A Medicine for treating eczema and its preparing process
08/23/2000CN1263762A Cosmetic composite and method for reducing skin aging procedure
08/23/2000CN1055636C External ointment for eczema and dermatitis
08/23/2000CN1055631C Chinese herbal medicine preparation for treating virus skin diseases
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107466 Acceleration of wound healing by photodynamic therapy
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6106848 Anionic amphiphilic polymer emulsifier
08/22/2000CA2194158C Desquamation compositions
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047758A2 Methods of making compounds
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047729A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
08/17/2000WO2000047722A2 Chimeric virus-like particles or chimeric capsomers from bvp (bovine papilloma virus)
08/17/2000WO2000047716A2 Fibres for culturing eukaryotic cells
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047184A1 Skin sanitizing compositions
08/17/2000WO2000047183A1 Skin sanitizing compositions
08/17/2000WO2000047179A1 Skin lightening agents
08/17/2000WO2000047177A1 Use of nanoscale chitosanes and/or chitosane derivatives
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000047045A1 Preservative compounds and compositions
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000009109A3 Pipecolic acid derivatives for vision and memory disorders
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000DE19905883A1 Chimäre Virus-ähnliche Partikel bzw. chimäre Capsomere von BPV Chimeric virus-like particles or chimeric capsomeres of BPV
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2361334A1 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027351A1 Phenanthroline derivatives
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027098A1 Electrically activated substance and method for making the same
08/16/2000EP1027064A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations
08/16/2000EP1027046A1 Antagonists of gonadotropin releasing hormone
08/16/2000EP1027045A1 Methods and compositions for regulation of 5-alpha reductase activity
08/16/2000EP0812194B1 Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis
08/16/2000EP0463126B1 Methods of enhancing wound healing and tissue repair
08/16/2000CN1263522A Compounds and methods for inhibition of expression of VCAM-1
08/16/2000CN1263462A Monoesters of probucol for treatment of cardiovascular and inflammatory disease
08/16/2000CN1263459A Mild antimicrobial wipes
08/16/2000CN1262956A Skin cleaning agent
08/16/2000CN1262950A Linjunsha medicine
08/16/2000CN1262936A Medicine for curing psoriasis
08/16/2000CN1262930A Chinese medicine Lidanxiaodou liquor
08/16/2000CN1262922A Cosmetic or skin-protecting composition containing at least one kind of alkynyl carbamate and polyol
08/16/2000CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use
08/16/2000CN1055403C Medical ointment for treating scabies
08/16/2000CN1055392C Drug composition for curing psoriasis and its medicinal use
08/16/2000CN1055389C Composition and application against senile plaque formed on sin and/or slow death
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103880 Amino acid sequence of mitogenic peptide; angiogenic agents especially for brain structures; wound healing agents for skin; for bone regeneration especially osteoporosis
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/15/2000US6103739 Metalloproteinase inhibitors
08/15/2000US6103718 Selective cyclic nucleotide phosphodiesterase (pde) inhibitors (specifically of type 4) which are effective bronchial therapeutics; bronchodilators; respiratory system disorders
08/15/2000US6103702 Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response
08/15/2000US6103247 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it
08/15/2000US6103245 Topical barrier composition containing silicone and bentonite
08/15/2000US6103230 Methods for promoting wound healing and treating transplant-associated vasculopathy
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046389A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000WO2000046353A1 Sebocytes, sebocyte cell lines and applications thereof
08/10/2000WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
08/10/2000WO2000046252A1 Process for cross-linking hyaluronic acid to polymers
1 ... 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 ... 1065